FDA Panel Wants Limits on Anemia Drugs

Courtesy Headlines from the Associated Press  Thu, 03/13/2008 - 16:27

WASHINGTON (AP) -- Federal health advisers said anemia drugs sold by Amgen Inc. and Johnson & Johnson should only be used by a limited segment of chemotherapy patients - a restriction that could cost the companies millions....


 

More related items

FDA panel backs anemia drugs for kidney disease
ADELPHI, Md. (AP) -- Federal health advisers said Monday that patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can...

FDA panel split on withdrawing diet pill Meridia
ADELPHI, Md. (AP) -- Federal health advisers delivered a split opinion Wednesday on whether to withdraw the diet pill Meridia due to evidence that it increases heart attack and stroke, with...

FDA panel mixed on approving Cymbalta for pain
WASHINGTON (AP) -- A majority of federal health advisers say a best-selling antidepressant from Eli Lilly & Co. appears effective in treating back pain, but not arthritis....

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...

Burt's Bees Free Head to Toe Starter Kit


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com